For global pharmaceutical organisations

From study data to complete, validated dossier.

Metamorphic AI is built for pharmaceutical and biotech organisations that need to move faster, operate more efficiently, and deliver without compromising regulatory quality.

ISO 27001 CertifiedSOC 2 Type IIFull eCTD Document SuiteFDA · EMA · PMDAComplete Audit TrailCFR 21 Part 11 CompliantValidated with Pharma Partners
The problem

Decades of investment.
The bottleneck hasn't moved.

The manual authoring workflow has never had a natural efficiency ceiling. The more complex the pipeline, the more resource it consumes.

RESOURCE
More pipeline, more headcount.
The more complex the pipeline, the more resource it requires. There is no natural efficiency gain in the traditional model — growth compounds the problem.
QUALITY
Inconsistent. Hard to govern.
Quality is dependent on individual expertise. Inconsistent across the dossier, hard to standardise, and harder to scale as the portfolio grows.
REGULATORY BURDEN
Completeness over clarity.
A process that optimises for completeness over clarity adds to the regulatory review burden rather than reducing it — the opposite of what agencies need.

When AI is deployed tool by tool, without a layer to coordinate it, the gains compound into a new problem. Each document type gets its own tool, its own vendor, its own validation exercise. None of them share context with the others.

Specialist knowledge built into one tool is invisible to the next. A clinical judgement applied consistently in one document has no way of propagating across the dossier. The review burden that was supposed to shrink instead grows.

More investment in siloed AI deepens the problem. It doesn't solve it.

THIS IS
The Agentic Value Trap.
THE WAY OUT
One orchestration engine. Every document.
The Metamorphic AI orchestration engine enables a singular system to carry the same clinical knowledge, regulatory logic, and terminology across every document in the dossier — by design, not by integration.
THE RESULT
Consistency that compounds.
Documents that are supposed to tell the same clinical story do. Every figure reconciled automatically. Every regulatory standard enforced uniformly. Across the full dossier, every time.
The platform

One platform. Every document.
Your standards.

Metamorphic AI covers the full eCTD document suite under a single, governed platform that enforces consistency across every document in your dossier. Configured to your organisation's standards. Certified to ISO 27001 and SOC 2 Type II.

Metamorphic Works

Autonomous authoring from study data to complete, validated report — with zero copy-paste and near-zero data errors.

Complete, validated outputProduces a complete, validated document that reflects your organisation's writing standards, regulatory requirements, and established practices.
Direct from source dataStatistical outputs flow directly into document generation — eliminating the copy-paste handoff that is the primary source of data errors in manual workflows.
Near-zero data errorsEvery figure reconciled against its source data automatically.
Consistent across the dossierEvery document draws from the same governed knowledge base — the same data, the same terminology, the same regulatory logic.
FULL ECTD COVERAGE
CSRClinical SummariesOverviewsProtocolsInvestigator BrochuresInformed ConsentPlain Language SummariesMeeting PackagesRegulatory OverviewsTFLsADaM Datasets
COMPLIANCE & SECURITY
ISO 27001 certified
SOC 2 Type II certified
FDA CFR 21 Part 11 compliant
Full regulatory audit trail across all documents
Your standards and study data fully isolated
Designed for validated pharmaceutical environments
Results

What the transformation
looks like in practice.

From a large-scale transformation programme led by the Metamorphic AI founders, validated with pharma partners. The figures reflect a single document type — the Clinical Study Report — at an organisation producing between 70 and 100 CSRs per year.

METRICMANUALMETAMORPHIC AI
CSR authoring time60–80 days10–30 minutes
Per-reviewer review timeDays to weeks20–40 minutes
Time to final document12–15 weeksSame day as final data
FTEs for CSR production~503
CSRs per writer per year2–3Up to 100
Data errors per CSR~40Near zero
Review comment trendStable / growingDeclining with each CSR
>90%
Reduction in time to final document
12–15 WEEKS → SAME DAY AS FINAL DATA
50→3
FTEs required for CSR production
FROM A LARGE-SCALE PRIOR TRANSFORMATION
"This is a step in the right direction — a well written succinct CSR can ease review by objectively describing data."
EX-DEPUTY DIVISION HEAD, FDA
The transformation

Built by people who have
delivered this before.

Metamorphic AI was founded by Louise Lind Skov and Waheed Jowiya, who bring over 25 years of combined experience in pharmaceutical medical writing and regulatory affairs.

Before founding Metamorphic AI, the founders led one of the most significant document automation transformations in the industry at a major global pharmaceutical company — gaining direct experience of what it actually takes to change this process in a regulated enterprise environment.

That programme demonstrated that the clinical evidence pipeline could be fundamentally redesigned. Metamorphic AI was founded to deliver that transformation at scale.

WHAT A REAL TRANSFORMATION REQUIRES

Available technology has reached the limits of what it can deliver within unchanged workflows. A real transformation requires four things working together.

Technology matched to the problem

Identifying the bottleneck before building the solution prevents the common failure mode of deploying tools into an unchanged process.

Process genuinely redesigned

The shift to an AI-enabled workflow requires genuine redesign — not new tools bolted onto an old way of working.

People transitioned deliberately

Role changes announced rather than managed are the single most consistent reason AI deployments fail to deliver sustained value at scale.

Knowledge that compounds

The platform improves with every document it processes. Organisations that invest from the first deployment extract compounding value.

Role evolution, not role elimination.

A structured transition programme — moving teams through defined stages as confidence and output quality build, so the organisation extracts value at every point in the journey.

01
Working alongside
Teams work alongside the platform — reviewing outputs and building institutional familiarity. Human expertise remains central.
02
Shifting to refinement
As output quality matures, effort moves from creation to refinement — a more leveraged application of expertise.
03
Point of judgement
Human involvement concentrates on clinical narrative, regulatory integrity, and decisions that require genuine expertise.
04
Strategic oversight
A small, highly capable team governs the platform and owns the strategic clinical narrative across the portfolio.
Get started

Not a vendor.
We deliver the outcome.

We start with a conversation about your process, your constraints, and your timeline — then show you precisely how the platform addresses them.